ClinicalTrials.Veeva

Menu

A Multi-Center Study to Evaluate Acute Safety and Clinical Performance of Paladin® Carotid Post-Dilation Balloon System With Integrated Embolic Protection

C

Contego Medical

Status

Completed

Conditions

Carotid Artery Stenoses

Treatments

Device: carotid artery stenting

Study type

Observational

Funder types

Industry

Identifiers

NCT02501148
CSP-1001

Details and patient eligibility

About

The purpose of this study is to assess the safety and clinical performance of Paladin System in patients with carotid artery stenosis.

Enrollment

106 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Documented stenotic atherosclerotic lesion located at carotid bifurcation and / or proximal internal carotid artery (ICA)
  • Subject is either (A) symptomatic within 6 months of procedure, with an ipsilateral carotid stenosis ≥ 50% by angiography, or (B) asymptomatic with carotid stenosis ≥ 70% by angiography
  • Target lesion can be covered by a single stent of no more than 40 mm in length
  • Target lesion reference vessel diameter (RVD) is 4.0 mm - 7.0mm
  • Sufficient landing zone required for successful deployment of integrated embolic protection filter
  • Willing to comply with all follow-up required study visits
  • Provision of written informed consent before index procedure

Exclusion criteria

  • Life expectancy of less than one year
  • An evolving, acute or recent stroke within 14 days of study evaluation
  • Acute myocardial infarction within 72 hours before procedure
  • Known sensitivity to contrast media that cannot be adequately controlled with pre-medication
  • Subject has a total occlusion of target carotid artery
  • Subject has a previously place stent in ipsilateral carotid artery
  • Severe circumferential lesion calcification that may restrict full deployment of carotid stent
  • Presence of filling defect or thrombus in target vessel
  • Presence of "string sign" of target vessel
  • Carotid (intracranial) stenosis located distal to target lesion
  • Greater than 50% stenosis of common carotid artery proximal to target lesion.
  • Known mobile plaque in aortic arch

Trial design

106 participants in 1 patient group

Carotid artery stenting
Description:
Symptomatic and asymptomatic subjects requiring carotid artery stenting, post-dilation performed using the Paladin System with integrated embolic protection
Treatment:
Device: carotid artery stenting

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems